APRICUS BIOSCIENCES, INC. Warrant for the Purchase of Shares of Common Stock, Par Value $0.001 per ShareWarrant Agreement • September 28th, 2010 • Apricus Biosciences, Inc. • Pharmaceutical preparations • California
THIS CERTIFIES that, _____, or its registered assigns, is the registered holder of this Warrant (the “Holder”) to subscribe for, and purchase from, Apricus Biosciences, Inc., a Nevada corporation (the “Company”), upon the terms and conditions set forth herein, at any time or from time to time after the date this warrant is issued (the “Initial Exercise Date”) until five years after the Issue Date (the “Exercise Period”), up to an aggregate of ____________ shares of common stock, par value $0.001 per share (the “Common Stock”), of the Company. This Warrant is initially exercisable at a price of $___ per share, subject to adjustment as described in this Warrant. The term “Exercise Price” shall mean, depending on the context, the initial exercise price (as set forth above) or the adjusted exercise price per share. The Company may, in its sole discretion, reduce the then current Exercise Price to any amount or extend the Exercise Period, at any time. Such modifications to the Exercise Pric
WARRANT AGENT AGREEMENTWarrant Agent Agreement • September 28th, 2010 • Apricus Biosciences, Inc. • Pharmaceutical preparations • California
WARRANT AGENT AGREEMENT, dated as of September 17, 2010 (“Agreement”), between Apricus Biosciences, Inc., a Nevada corporation (the “Company”), and Wells Fargo Bank, N.A. (the “Warrant Agent”).
